课题基金 / 基金详情

自噬介导小胶质细胞代谢重编程参与慢性低灌注脑白质损伤的机制研究

批准号:
82071380
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
田代实
依托单位:
学科分类:
神经损伤、修复与再生
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
田代实

项目摘要

结项摘要

田代实的其他基金

相似基金

相关文献

中文摘要
慢性低灌注脑白质损伤(WMI)是血管性认知功能障碍的重要原因,核心病理特征是髓鞘脱失和小胶质细胞(MG)活化。不同表型MG介导的炎症微环境是影响受损髓鞘修复的重要因素。我们前期研究发现,WMI后活化的MG内聚集大量自噬小体,调控自噬可维持MG的抗炎状态,更有利于髓鞘修复。细胞代谢组学的初步结果也提示,MG活化后细胞内糖脂代谢旺盛,抑制自噬信号可诱导MG代谢重编程,并导致亚油酸等脂质蓄积。据此推测,WMI后MG自噬失衡,启动以糖酵解为主的能量代谢,活化并维持MG的慢性炎症状态,参与介导脑白质脱髓鞘的病理过程;抑制MG自噬后,出现由糖酵解转向脂质代谢的重编程现象,调控MG表型由不利于髓鞘修复的促炎型向抗炎型转化。本研究拟通过MG消融、基因敲除、调控代谢等手段,阐明MG代谢重编程参与WMI后神经炎症的分子机制,以改善受损髓鞘的再生微环境,重建神经单元的内稳态,为WMI后认知障碍提供新的治疗思路。
英文摘要
Cerebral small vessel disease, manifested as white matter ischemia (WMI), is very common clinically. The core pathological features are demyelination, followed by activation of microglia (MG). Immunologic process mediated by microglia activation control microenvironment state of myelin regeneration, which is one of crucial factors for the differentiation, maturation and re-myelination of oligodendrocyte progenitor cells. Microenvironment change of myelin regeneration is highly dependent on functional subpopulation of microglia, in which anti- inflammatory (M2) subtype is beneficial to myelin repair. In our previous reports, the aggregation of autophagic bodies was found in activated microglia after WMI and the regulation of MG autophagy can maintain the anti-inflammatory state of MG, which is more beneficial to myelin repair. Our preliminary results of microglial metabonomics also suggested that in the state of MG activation and inhibition of autophagy, metabolic reprogramming occurred, intracellular glycolipid metabolism was exuberant, and linoleic acid and other lipids accumulated. It is speculated that the autophagy imbalance of MG after WMI initiates glycolysis-based metabolic reprogramming, then activates and maintains the chronic inflammatory state of MG, finally mediates the pathological process of demyelination; however, when inhibiting the process of autophagy, the metabolic level of microglia changes from glycolysis to lipid metabolism. It mediates the transformation of MG phenotype from pro-inflammatory type to anti-inflammatory type. The purpose of this study is to clarify the molecular mechanism of metabolic reprogramming mediated by MG autophagy in neuroinflammation after WMI. Several methods, including MG ablation, gene knockout and metabolic reprogramming, will be used in our study. M2 microglia modulated by cellular metabolic reprogramming might provide a beneficial microenvironment for myelin regeneration and is helpful for tissue reconstruction and functional restoration, which might be a novel and potential method to treat vascular cognitive decline after WMI in the future.
慢性低灌注脑白质损伤(White Matter Injury, WMI)是血管性认知功能障碍的重要原因,核心病理特征是髓鞘脱失和小胶质细胞活化。本研究围绕慢性低灌注脑白质损伤模型,探讨了小胶质细胞自噬介导的代谢重编程在髓鞘损伤和修复中的作用。WMI后小胶质细胞自噬溶酶体水平显著激活,急性期抑制小胶质细胞自噬可以缓解神经炎症,并促进小胶质细胞表型向促髓鞘再生方向转变。自噬抑制还显著增强了小胶质细胞对髓鞘碎片的降解能力,改善了髓鞘再生的微环境。通过代谢组学和转录组学联合分析,发现亚油酸(CLA)是调节小胶质细胞代谢的重要脂质代谢产物,CLA处理能够通过PPAR-γ通路调节小胶质细胞表型,恢复小胶质细胞促再生特性,减轻炎症反应并促进髓鞘再生修复及认知功能改善。本研究首次揭示了小胶质细胞自噬在WMI后髓鞘损伤和修复中的机制,为调控小胶质细胞代谢重编程以改善WMI的临床治疗提供了理论依据和新思路。相关研究成果已累计发表SCI论文8篇。
小胶质细胞TREM2-PLIN5调控脂滴-线粒体互作参与脑缺血白质损伤后髓鞘修复的分子机制
  • 批准号:
    82371404
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    田代实
  • 依托单位:
HV1调控小胶质细胞自噬介导的神经炎症在慢性脑缺血白质损伤中的作用机制
  • 批准号:
    81873743
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2018
  • 负责人:
    田代实
  • 依托单位:
S1P/mTOR轴介导小胶质细胞表型转化在脑白质缺血后髓鞘再生微环境中的作用
  • 批准号:
    81571132
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    田代实
  • 依托单位:
EGFR/mTOR通路靶向调控脑梗塞后反应性胶质增生和轴突再生微环境的实验研究
  • 批准号:
    81171157
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2011
  • 负责人:
    田代实
  • 依托单位:
国内基金
海外基金